Ausgabe 9/2016
Inhalt (24 Artikel)
Is 18FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?
David Groheux, Elif Hindié
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
Su Hyun Lee, Seunggyun Ha, Hyun Joon An, Jae Sung Lee, Wonshik Han, Seock-Ah Im, Han Suk Ryu, Won Hwa Kim, Jung Min Chang, Nariya Cho, Woo Kyung Moon, Gi Jeong Cheon
Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
Bernhard Nilica, Dietmar Waitz, Vlado Stevanovic, Christian Uprimny, Dorota Kendler, Sabine Buxbaum, Boris Warwitz, Llanos Gerardo, Benjamin Henninger, Irene Virgolini, Margarida Rodrigues
Role of 68Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
Vikas Prasad, Aurora Sainz-Esteban, Ruza Arsenic, Ursula Plöckinger, Timm Denecke, Ulrich-Frank Pape, Andreas Pascher, Peter Kühnen, Marianne Pavel, Oliver Blankenstein
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial
Cristina Nanni, Lucia Zanoni, Cristian Pultrone, Riccardo Schiavina, Eugenio Brunocilla, Filippo Lodi, Claudio Malizia, Matteo Ferrari, Patrizio Rigatti, Cristina Fonti, Giuseppe Martorana, Stefano Fanti
Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing
Ali Afshar-Oromieh, Henrik Hetzheim, Wolfgang Kübler, Clemens Kratochwil, Frederik L. Giesel, Thomas A. Hope, Matthias Eder, Michael Eisenhut, Klaus Kopka, Uwe Haberkorn
RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study
Shih-Hsin Chen, Hung-Ming Wang, Chien-Yu Lin, Joseph Tung-Chieh Chang, Chia-Hsun Hsieh, Chun-Ta Liao, Chung-Jan Kang, Lan-Yan Yang, Tzu-Chen Yen
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei
Julien Dubreuil, Francesco Giammarile, Pascal Rousset, Naoual Bakrin, Guillaume Passot, Sylvie Isaac, Olivier Glehen, Andrea Skanjeti
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study
Seung Hyup Hyun, Jae Seon Eo, Jeong Won Lee, Joon Young Choi, Kyung-Han Lee, Sae Jung Na, Il Ki Hong, Jin Kyoung Oh, Yong An Chung, Bong-Il Song, Tae-Sung Kim, Kyung Sik Kim, Dae Hyuk Moon, Mijin Yun
18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease
Verena Ruhlmann, Thorsten Dirk Poeppel, Alexander Sascha Brandt, Johannes Grüneisen, Marcus Ruhlmann, Jens Matthias Theysohn, Michael Forsting, Andreas Bockisch, Lale Umutlu
[11C]TASP457, a novel PET ligand for histamine H3 receptors in human brain
Yasuyuki Kimura, Chie Seki, Yoko Ikoma, Masanori Ichise, Kazunori Kawamura, Keisuke Takahata, Sho Moriguchi, Tomohisa Nagashima, Tatsuya Ishii, Soichiro Kitamura, Fumitoshi Niwa, Hironobu Endo, Makiko Yamada, Makoto Higuchi, Ming-Rong Zhang, Tetsuya Suhara
Ability of 18F-DOPA PET/CT and fused 18F-DOPA PET/MRI to assess striatal involvement in paediatric glioma
Giovanni Morana, Matteo Puntoni, Maria Luisa Garrè, Michela Massollo, Egesta Lopci, Merhdad Naseri, Mariasavina Severino, Domenico Tortora, Andrea Rossi, Arnoldo Piccardo
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers
Philip J. O’Halloran, Thomas Viel, David W. Murray, Lydia Wachsmuth, Katrin Schwegmann, Stefan Wagner, Klaus Kopka, Monika A. Jarzabek, Patrick Dicker, Sven Hermann, Cornelius Faber, Tim Klasen, Michael Schäfers, David O’Brien, Jochen H. M. Prehn, Andreas H. Jacobs, Annette T. Byrne
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Konstantinos Chiotis, Laure Saint-Aubert, Irina Savitcheva, Vesna Jelic, Pia Andersen, My Jonasson, Jonas Eriksson, Mark Lubberink, Ove Almkvist, Anders Wall, Gunnar Antoni, Agneta Nordberg
Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease
Solveig Tiepolt, Swen Hesse, Marianne Patt, Julia Luthardt, Matthias L. Schroeter, Karl-Titus Hoffmann, David Weise, Hermann-Josef Gertz, Osama Sabri, Henryk Barthel
In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [18F]GE-180 and effect of docosahexaenoic acid
J. L. Tremoleda, O. Thau-Zuchman, M. Davies, J. Foster, I. Khan, K. C. Vadivelu, P. K. Yip, J. Sosabowski, W. Trigg, A. T. Michael-Titus
The EANM practice guidelines for bone scintigraphy
T. Van den Wyngaert, K. Strobel, W. U. Kampen, T. Kuwert, W. van der Bruggen, H. K. Mohan, G. Gnanasegaran, R. Delgado-Bolton, W. A. Weber, M. Beheshti, W. Langsteger, F. Giammarile, F. M. Mottaghy, F. Paycha
18F-FDG PET/CT in patients with idiopathic retroperitoneal and mediastinal fibrosis
R. Fernández-López, J. A. Lojo, I. Acevedo-Báñez, R. González-León, I. Borrego-Dorado
Severe early basal ganglia hypometabolism in neurodegeneration with brain iron accumulation
Ismini C. Mainta, C. Tabouret-Viaud, J. Horvath, M. I. Vargas, V. Garibotto
William T. O’Brien Sr. (Ed.), Top 3 Differentials in Neuroradiology: A Case Review. Thieme Medical Publishers, Inc., 2015. ISBN 978-1- 60406-723-1
Davide D’Arienzo, Luigi Mansi
Andreas Engert and Anas Younes (Eds), Hodgkin Lymphoma: A Comprehensive Overview
Flavia Galante, Luigi Mansi
Andrew M. Evens and Kristie A. Blum (Eds), Non-Hodgkin Lymphoma. Pathology, Imaging, and Current Therapy
Sara Pellegrino, Luigi Mansi
Erratum to: Dual-phase amyloid PET: hitting two birds with one stone
Valentina Garibotto, Silvia Morbelli, Marco Pagani